Tysabri 300 MG per 15 ML Injection

RxCUI
603541
RxNorm name
Tysabri 300 MG per 15 ML Injection
Display name
Tysabri 300 MG per 15 ML Injection
Full name
Tysabri 300 MG per 15 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125104Tysabrinatalizumab351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TYSABRINATALIZUMABBiogen Inc.c5fdde91-1989-4dd2-9129-4f3323ea29622025-03-21Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 603541

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
c5fdde91-1989-4dd2-9129-4f3323ea2962Tysabri 300 MG per 15 ML InjectionSY47These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI. TYSABRI (natalizumab) injection, for intravenous use Initial U.S. Approval: 200420250321
c5fdde91-1989-4dd2-9129-4f3323ea296215 ML natalizumab 20 MG/ML Injection [Tysabri]SBD47These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI. TYSABRI (natalizumab) injection, for intravenous use Initial U.S. Approval: 200420250321
c5fdde91-1989-4dd2-9129-4f3323ea2962Tysabri 300 MG in 15 ML InjectionPSN47These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI. TYSABRI (natalizumab) injection, for intravenous use Initial U.S. Approval: 200420250321
c5fdde91-1989-4dd2-9129-4f3323ea296215 ML Tysabri 20 MG/ML InjectionSY47These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI. TYSABRI (natalizumab) injection, for intravenous use Initial U.S. Approval: 200420250321